Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.378NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.206NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.77NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.13.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBENSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.57NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EF.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.8.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ED.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BU.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCGNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DT.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCANSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.50NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.77 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.10.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EF.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used